BC
GNMX
Birchview Capital’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-128,000
| Closed | -$19K | – | 56 |
|
|
2019
Q3 | $19K | Hold |
128,000
| – | – | 0.01% | 50 |
|
|
2019
Q2 | $20K | Hold |
128,000
| – | – | 0.01% | 54 |
|
|
2019
Q1 | $25K | Hold |
128,000
| – | – | 0.02% | 53 |
|
|
2018
Q4 | $90K | Hold |
128,000
| – | – | 0.09% | 49 |
|
|
2018
Q3 | $157K | Hold |
128,000
| – | – | 0.1% | 49 |
|
|
2018
Q2 | $142K | Hold |
128,000
| – | – | 0.1% | 49 |
|
|
2018
Q1 | $257K | Hold |
128,000
| – | – | 0.17% | 42 |
|
|
2017
Q4 | $154K | Hold |
128,000
| – | – | 0.09% | 35 |
|
|
2017
Q3 | $161K | Hold |
128,000
| – | – | 0.08% | 34 |
|
|
2017
Q2 | $170K | Buy |
128,000
+60,000
| +88% | +$79.7K | 0.09% | 35 |
|
|
2017
Q1 | $126K | Buy |
68,000
+20,000
| +42% | +$37.1K | 0.07% | 41 |
|
|
2016
Q4 | $249K | Buy |
48,000
+14,000
| +41% | +$72.6K | 0.15% | 32 |
|
|
2016
Q3 | $189K | Buy |
+34,000
| New | +$189K | 0.11% | 39 |
|